The investigators conducted a prospective, randomized double-blind, placebo-controlled study based on a placebo technique to evaluate the efficacy of T-MPNS vs placebo in women with idiopathic OAB.
The main questions aimed to be answered are:
What are the effects of Transcutaneous Medial Plantar Nerve Stimulation (T-MPSS) on clinical parameters related to incontinence and quality of life compared to the placebo group in women with idiopathic overactive bladder (OAB)? Participants (n:40) with idiopathic OAB who meet the exclusion and inclusion criteria will be divided into 2 groups using a randomization table. The first group will receive T-MPSS (n:20) and the second group will receive placebo T-MPSS (n:20). Measurements will be performed twice in total, before and at the end of treatment (6th week).
Women over the age of 18 with clinical diagnosis of idiopathic OAB
Not tolerated or unresponsive to antimuscarinics and discontinued at least 4 weeks
Able to understand the procedures, advantages and possible side effects
Willing and able to complete the voiding diary and QoL questionnaire
Women with stress urinary incontinence
History of conservative therapy (T-MPNS and Transcutaneous Tibial Nerve Stimulation/PTNS) within 6 months
Pregnancy or intention to become pregnant during the study
Current vulvovaginitis or urinary tract infections or malignancy